a2z Radiology AI vs Sensodyne

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Sensodyne

EmergingBeauty & Personal Care

Toothpaste

Haleon (HLN) world's #1 sensitive teeth toothpaste in 130+ countries; $2B+ revenue with clinical desensitizing formulas and dentist-recommended positioning competing with Colgate Sensitive.

AI VisibilityBeta
Overall Score
D31
Category Rank
#3 of 5
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
27
Perplexity
41
Gemini
29

About

Sensodyne is the world's #1 dentist-recommended toothpaste brand for sensitive teeth — owned by Haleon plc (LSE/NYSE: HLN), the consumer healthcare company spun out of GlaxoSmithKline in 2022. Sensodyne's clinically proven formulations (potassium nitrate or stannous fluoride as active desensitizing ingredients) treat and prevent tooth sensitivity while providing cavity protection, enamel strengthening, and whitening benefits. Available in 130+ countries and generating approximately $2+ billion in annual retail sales, Sensodyne is Haleon's largest brand and one of the world's most profitable consumer healthcare products.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.